Skip to Main Content

WASHINGTON — A key House committee is preparing for a hearing on drug pricing, as Republicans show an increasing willingness to examine an issue frustrating their constituents.

Rep. Michael Burgess of Texas, who helms the health subcommittee of the Energy and Commerce Committee, told STAT Thursday his subcommittee will hold a hearing on the drug pricing issues, as well as the related “supply chain.” Neither he nor the full panel chairman, Rep. Greg Walden of Oregon, suggested the hearing had yet been scheduled.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

  • Day of reckoning or artificial song and dance is coming and soon. Lot of hoopla but no concrete results would be the case in our legalized corrupt election system. Legislators need pharmaceutical money to get elected. They will not touch the golden goose.

Comments are closed.